Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development
2017-10-31 16:32
NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research
2017-10-18 15:05
NeuroVive's Collaborator, the Children's Hospital of Philadelphia Awarded NIH Grant to Study NVP015 Against Chemical Threats
2017-10-06 05:44
NeuroVive Appoints Daniel Schale as Director of Communications
2017-10-04 15:00
NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease
2017-06-27 17:17
NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project
2017-06-01 19:52
NeuroVive to Continue NeuroSTAT® Clinical Development After Positive Outcome in Preclinical and Clinical TBI Studies
2017-05-23 15:04
NeuroVive Pharmaceutical AB Interim Report January - March 2017
2017-05-18 15:18
NeuroVive Invitation to Conference Call and Web Cast on in-licensing Agreement With Yungjin Pharm
2017-05-02 15:01
NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm
2017-05-02 11:51
NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects
2017-04-20 15:05
NeuroVive's Lead NASH Project to be Presented at The International Liver Congress(TM)
2017-04-05 17:32
Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)
2017-03-31 19:23
NeuroVive Pharmaceutical AB Publishes 2016 Annual Report
2017-03-23 16:45
Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB
2017-03-23 16:13
NeuroVive Appoints Recognized Scientific Advisors and Enters Research Agreements in NASH and Hepatocellular Carcinoma
2017-02-22 19:05
NeuroVive Pharmaceutical AB Year End Report January - December 2016
2017-02-21 16:01
NeuroVive's new Generation of Sanglifehrin-based Compounds Demonstrate Potent Inhibitory Effects on Human Hepatocellular Cancer Cells
2017-02-02 16:47
NeuroVive Redirects Research Resources From Asian Subsidiary to Parent
2017-01-25 16:09
NeuroVive Signs Mitochondrial Medicine Research Agreement With US key Opinion Leader
2017-01-23 16:03
1
2
3
4